People v. Eli Lilly & Co. et al., No. 23STCV00719 (Super. Ct. L.A. Cty. Jan. 12, 2023)

California sued the largest insulin makers and PBMs, alleging that they drove up the cost of the drug through unlawful, unfair and deceptive business practices in violation of Cal. Bus & Prof. Code 17200, et. seq. The three manufacturers named in the lawsuit produce over 90% of the global insulin supply and the three PBMs…

Read More →

FTC and Plaintiff States v. Syngenta Crop Protection AG, No. 22-cv-828 (M.D. N.C. Nov. 2022)

The FTC and 10 states sued pesticide manufacturers Syngenta Crop Protection and Corteva, Inc. two of the largest pesticide manufacturers operating in the United States. For allegedly paying distributors to block competitors from selling their cheaper generic products to farmers. The complaint alleges that these big pesticide firms run so-called “loyalty programs” in which distributors…

Read More →

FTC and Plaintiff States v. Amazon.com, Inc., No. 2:23-cv-01495 (W.D. Wash. Sept. 26, 2023)

The FTC and plaintiff states alleged that Amazon, an online retail and technology company, is a monopolist that uses a set of interlocking anticompetitive and unfair strategies to illegally maintain its monopoly power. The lawsuit alleges that Amazon’s actions allow it to stop rivals and sellers from lowering prices, degrade quality for shoppers, overcharge sellers,…

Read More →

New York et al. v. Meta (originally Facebook Inc.), No. 20-3589 (D.D.C.)

Forty-eight plaintiff states filed a lawsuit against Facebook Inc., alleging that the company harms the public by illegally stifling competition to protect its monopoly power. The states alleged that, over the last decade, the social networking giant illegally acquired competitors in a predatory manner and cut services to smaller firms that threatened its power, depriving…

Read More →

United States et al. v. Google LLC, No. 1:23-cv-00108 (E.D. Va. Jan. 24, 2023)

The United States and eight plaintiff states sued Google for monopolizing multiple digital advertising technology products in violation of Sections 1 and 2 of the Sherman Act. The complaint alleges that Google monopolizes key digital advertising technologies, collectively referred to as the “ad tech stack,” that website publishers depend on to sell ads and that…

Read More →

Texas et al. v. Google (In re Google Digital Advertising Antitrust Litigation), No. 1:21-cv-06841 (S.D.N.Y.)

The plaintiff states originally filed their case in the Eastern District of Texas (No. 4:20-cv-00957 (E.D. Tex. Dec. 16, 2020) alleging that Google monopolized or attempted to monopolize products and services used by advertisers and publishers in online-display advertising on third-party sites. The complaint also alleged that Google engaged in false, misleading and deceptive acts…

Read More →

Colorado et al. v. Google, No. 1:30-cv-03715 (D.D.C. Dec. 17, 2020)

Thirty-eight states sued Google, alleging that Google illegally maintains its monopoly power over general search engines and related general search advertising markets through a series of anticompetitive contracts and conduct, hurting both consumers and advertisers. Consumers are denied the benefits of competition, including the possibility of higher quality services and better privacy protections. Advertisers are…

Read More →

Utah et al. v. Google LLC, No. 3:21-cv-05227 (N.D. Cal. July 7, 2021)

Thirty-seven states filed a lawsuit against Google for monopolizing the smartphone application market in violation of state and federal antitrust laws. According to the complaint, Google operates a web of exclusionary agreements with phone manufacturers and carriers to exert control over app distribution on Android phones through its Google Play Store. By leveraging those anticompetitive…

Read More →

United States and Plaintiff States v. Google, No. 1:20-cv-03010 (D.D.C. Oct. 20, 2020)

Eleven states and the U.S. Department of Justice filed a lawsuit to prevent Google from unlawfully maintaining monopolies through anticompetitive and exclusionary practices in the search and search advertising markets. According to the complaint, Google accounted for almost 90 percent of all search queries in the United States. Google has entered into a series of…

Read More →

In the Matter of Investigation of Emergent BioSolutions, Inc.. Assurance No. 19-156 Dec. 31, 2019)

New York reached an agreement with Emergent BioSolutions, manufacturers of the opioid overdose reversal nasal spray NARCAN, to allow additional companies to gain access to the nasal spray delivery devices developed by Emergent. In February 2016, Adapt Pharma, Inc. launched a naloxone nasal spray, branded as NARCAN, in the United States. Naloxone has been used…

Read More →